European Approval for Sydnexis’ Pediatric Myopia Treatment
Sydnexis’ SYD-101 low-dose atropine formulation is now the first pharmaceutical option in Europe for myopia. The European Commission has granted…
DOT Lenses: Our new ally in the fight against childhood myopia?
One of the recent developments in myopia control for children is SightGlass Vision’s Diffusion Optics Technology (DOT) — a joint…
latest posts